Xos, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call
LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS), a leading electric truck manufacturer and fleet services provider, announced it is scheduling the release of its fourth quarter 2024 operating results on Friday, March 28, 2025 after the close of the U.S. financial markets.
Management will host a conference call to discuss these financial results at 4:30 p.m. Eastern Daylight Time / 1:30 p.m. Pacific Daylight Time that same day.
Conference Call and Webcast Details
Date / Time:
Friday, March 28, 2025, at 4:30 p.m. EDT / 1:30 p.m. PDT
Webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1709599&tp_key=0358d3de2e
U.S. Toll-Free Dial In:
1-833-816-1411
International Dial In:
1-412-317-0507
Conference ID:
9502065
To access the call, please dial in approximately ten minutes before the start of the call.
For those unable to participate in the live call, an audio replay will be available following the call through midnight Friday, March 28, 2025. To access the replay, please call 1-844-512-2921 or 1-412-317-6671 (International) and enter access code 10197245. A replay of the webcast will also be archived shortly after the call and can be accessed on the Company's website.
About Xos, Inc.Xos is a leading technology company, electric truck manufacturer, and fleet services provider for battery-electric fleets. Xos vehicles and fleet management software are purpose-built for medium- and heavy-duty commercial vehicles that travel on last-mile, back-to-base routes. The company leverages its proprietary technologies to provide commercial fleets with battery-electric vehicles that can be easier to maintain and more cost-efficient on a total cost of ownership (TCO) basis than their internal combustion engine counterparts. For more information, visit www.xostrucks.com.
Contacts
Xos Media Relationspress@xostrucks.com
Cautionary Statement Regarding Forward-Looking Statements
This website and other items we publish, including through social media outlets, may include 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words 'believe,' 'project,' 'expect,' 'anticipate,' 'estimate,' 'intend,' 'strategy,' 'future,' 'opportunity,' 'plan,' 'may,' 'should,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements, including but not limited to: (i) Xos, Inc.'s ('Xos') access to capital when needed and ability to continue as a going concern (ii) Xos's ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities, (iii) Xos' limited operating history, (iv) cost increases and supply chain shortages in the components needed for the production of Xos' vehicle chassis and battery system, (v) Xos' ability to meet production milestones and fulfill backlog orders, (vi) changes in the industries in which Xos operates, (vii) variations in operating performance across competitors, (viii) changes in laws and regulations affecting Xos' business, (viii) Xos' inability to implement its business plan or meet or exceed its financial projections (x) Xos' ability to retain key personnel and hire additional personnel, (xi) the risk of downturns and a changing regulatory landscape in the highly competitive electric vehicle industry and (xii) the outcome of any legal proceedings that may be instituted against Xos.
You should carefully consider the preceding factors and the other risks and uncertainties described in Xos' filings with the Securities and Exchange Commission (the 'SEC'), including its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Copies of Xos' SEC filings may be obtained by visiting Xos' Investors Relations website at investors.xostrucks.com or the SEC's website at www.sec.gov. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Xos assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
AIP Realty Trust Announces Non-Brokered Offering of Preferred Units and Provides Update on AllTrades Transaction and Concurrent Financing
Pursuant to the subscription agreements to be entered into between each subscriber and the Trust, each subscriber will be subject to, among other things (i) coattail provisions to be adhered to in the case of a potential transfer of Preferred Units and (ii) a covenant by the Trust to purchase the Preferred Units from the subscriber in the event that the Preferred Units are to convert pursuant to the designation, limitations, rights, privileges, restrictions and conditions attaching to the Preferred Units should a subscriber beneficially own, or exercise control or direction over that number of voting securities of the Trust which is greater than 9.9% of the total issued and outstanding voting securities of the Trust. Except as otherwise expressly provided in the Third Amended and Restated Declaration of Trust dated June 17, 2022 (the ' Declaration of Trust '), each Preferred Unit shall have the right to receive notice of and to attend any meetings of Trust's unitholders and to one vote for each Preferred Unit held. Holders of Preferred Units will also have the right to a proportionate share, in preference to the Units, of (i) all allocations (including allocations of income of the Trust), (ii) all advances or distributions of cash or other property (including amounts out of the income of the Trust or other amounts) and any other advances or distributions of a similar nature made in accordance with the Declaration of Trust; and (iii) the share of the Preferred Units in the remaining Trust assets on dissolution in accordance with the terms of the Declaration of Trust. Each Preferred Unit shall be convertible into one Unit at no additional cost, on the earlier of: (a) five (5) business days following the holder of such Preferred Units providing notice to the Trust of its intent to convert its Preferred Units; (b) the closing by the Trust of any merger, acquisition, plan of arrangement, restructuring, reverse take-over or other similar transaction involving the Trust; (c) at the option of the trustees of the Trust; and (d) April 30, 2027. The terms and conditions of the Preferred Units have been filed on the Trust's profile at . VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) -- AIP Realty Trust (the ' Trust ' or ' AIP ') (TSXV: AIP.U) is pleased to announce a non-brokered private placement (the ' Financing ') in which the Trust intends to issue up to 14,000,000 Preferred Units – Series B Convertible (each, a ' Preferred Unit '), at a price of US$0.50 per Preferred Unit for aggregate gross proceeds of up to US$7,000,000. Story Continues The net proceeds of the Financing will be used to fund the costs associated with the completion of AIP's proposed business combination (the 'AllTrades Transaction') with AllTrades Industrial Properties, LLC ('AllTrades') as previously disclosed by the Trust in a news release dated November 14, 2024, including costs related to audit fees, legal fees, preparation of necessary documentation for the AllTrades Transaction and due diligence costs. The Financing is being completed independent of the completion of the AllTrades Transaction with the funds being made available for AIP's use immediately upon closing thereof. Completion of the Financing remains subject to approval from the TSX Venture Exchange (the 'TSXV'). The Trust may pay finder's fees on a portion of the Financing, subject to compliance with the policies of the TSXV and applicable securities legislation. AllTrades Transaction Update The Trust is also pleased to provide an update on the progress of the AllTrades Transaction. As previously disclosed on November 14, 2024, the Trust, through its subsidiary AIP OP, LP, entered into a securities purchase agreement with 2024 ATIP, Inc. pursuant to which the Trust intends to acquire all of the issued and outstanding membership interests of AllTrades. In order to support the AllTrades Transaction and the purchase of the six completed AllTrades Serviced Industrial Business Suites, the Trust intends to complete a brokered private placement in which it will seek to raise aggregate gross proceeds of up to US$100,000,000 which will be used to finance the AllTrades Transaction purchase price, among other things. The Trust is currently engaged in advanced discussions with several leading banks who have shown interest in serving as lead investment banker of the syndicate to the Concurrent Financing. The transaction terms and ultimate structure of the Concurrent Financing remain under consideration and subject to negotiation with the syndicate members. Upon the entering into of an engagement letter with lead agent to the Concurrent Financing, the Trust will file and disseminate a news release disclosing the final terms. 'We are thrilled with the momentum we have on this transformative transaction with AllTrades,' said Leslie Wulf, Executive Chairman of the Trust. 'Our negotiations with the banks and the degree of interest we've received represent a crucial step towards securing the necessary financing to support our vision. We look forward to providing further updates as we continue to work diligently towards completing this transaction.' About AIP Realty Trust AIP Realty Trust is a real estate unit investment trust with a growing portfolio of AllTrades branded Service Industrial Business Suites ('SIBS') light industrial flex facilities focused on small businesses and the trades and services sectors in the U.S. These properties appeal to a diverse range of small space users, such as contractors, skilled trades, suppliers, repair services, last-mile providers, small businesses and assembly and distribution firms. They typically offer attractive fundamentals including low tenant turnover, stable cash flow and low capex intensity, as well as significant growth opportunities. With an initial focus on the Dallas-Fort Worth market, AIP plans to roll out this innovative property offering nationally. For more information, please visit For further information from the Trust, contact: Leslie Wulf Executive Chairman (214) 679-5263 Or Greg Vorwaller Chief Executive Officer (778) 918-8262 Cautionary Statement on Forward-Looking Information This news release contains statements which constitute 'forward-looking information' within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of AIP Realty Trust with respect to future business activities and operating performance. Forward-looking information is often identified by the words 'may', 'would', 'could', 'should', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' or similar expressions and includes information regarding the ability to obtain regulatory and unitholder approvals, the closing of the Financing and Concurrent Financing and aggregate proceeds to be raised thereunder, the use of proceeds to be raised under the Financing, negotiations with the agents regarding the particulars of the Concurrent Financing, the closing of the AllTrades Transaction and other factors. When or if used in this news release, the words 'anticipate', 'believe', 'estimate', 'expect', 'target', 'plan', 'forecast', 'may', 'schedule' and similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to proposed financing activity, proposed acquisitions, regulatory or government requirements or approvals, the reliability of third-party information and other factors or information. Such statements represent the Trust's current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Trust, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward- looking statements. The Trust does not intend, and do not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations. The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this news release are made as of the date of this news release. AIP does not undertake to update any such forward- looking information whether as a result of new information, future events or otherwise, except as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release is not an offer of securities for sale in the United States. The securities may not be offered or sold in the United States absent registration or an exemption from registration under U.S. Securities Act of 1933, as amended (the 'U.S. Securities Act'). The Trust has not registered and will not register the securities under the U.S. Securities Act. The Trust does not intend to engage in a public offering of their securities in the United States. Source: AIP Realty Trust
Yahoo
30 minutes ago
- Yahoo
Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science
Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ('Jupiter' or the 'Company'), a clinical-stage pharmaceutical company developing JOTROL™, a proprietary resveratrol-based platform, today announced the official commercial launch of Nugevia™, its consumer longevity product line. The launch represents a pivotal milestone in Jupiter's strategy to generate near-term revenue while maintaining momentum in its clinical pipeline. Nugevia's debut comes as global demand accelerates for scientifically validated wellness solutions that extend healthspan and enhance mental and metabolic resilience. Backed by over eight years of pharmaceutical development, powered by Jupiter's proprietary JOTROL™ micellar delivery technology, Nugevia products bring a clinical-grade standard to the nutraceutical space. 'The launch of Nugevia is the natural next step in translating our science into broad, real-world impact,' said Christer Rosén, Chairman and CEO of Jupiter Neurosciences. 'By building on the same proprietary technology platform that underpins our prescription drug development, we're delivering a differentiated consumer offering with unmatched bioavailability and scientific credibility.' A New Standard in Evidence-Based Supplementation Nugevia's first three formulations—targeting mitochondrial support, mental clarity, and "beauty from within"—will be sold via a direct-to-consumer (DTC) model starting in Q3 2025. Each product integrates JOTROL™, Jupiter's enhanced resveratrol formulation that demonstrated a 9x improvement in bioavailability during clinical trials. JOTROL™ is also the foundation of Jupiter's ongoing therapeutic programs in Parkinson's and Alzheimer's disease. Unlike typical single-ingredient supplements, Nugevia features precision-engineered "intelligent stacking" of synergistic compounds designed to enhance cellular resilience, support blood-brain barrier delivery, and promote system-wide optimization. 'We cracked the code on resveratrol's widely published issue with bioavailability, and now we're unlocking its potential beyond the clinic,' added Rosén. 'Consumers are seeking longevity solutions that are both credible and effective. Nugevia meets that demand.' Strategic Synergy with Core Pipeline The Nugevia launch adds a new dimension to Jupiter's value proposition as a dual-path company—advancing clinical-stage therapies for CNS disorders while monetizing its platform in the booming longevity market, projected to reach $8 trillion by 2030. The Company expects this initiative to provide a self-reinforcing commercial engine, with revenues from Nugevia supporting ongoing clinical trials and expanding its shareholder-aligned business model. 'Nugevia represents more than a product launch—it's a strategic engine for growth,' said Rosén. 'By leveraging our core science in a consumer format, we're creating a near-term revenue stream that supports our therapeutic pipeline and strengthens long-term shareholder value. It's smart capital allocation with real scientific impact.' A digital press kit, including high-resolution product imagery and key brand information, is available at . About Jupiter Neurosciences, Inc. Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's platform product, JOTROL™, is an enhanced orally administered resveratrol formulation designed and intended to deliver therapeutically relevant, safe levels of resveratrol. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS. More information may be found on the Company's website About JOTROL Resveratrol is one of the world's most extensively researched molecules. Thorough evaluation has shown that for the compound to be effective, it requires a high C-Max (~300 ng/ml of resveratrol in plasma), achievable only with doses exceeding 3 grams using earlier resveratrol products. Poor bioavailability has been a well-documented issue with resveratrol. Doses over 2 grams have been associated with severe gastrointestinal (GI) side effects, which have prevented the compound from receiving regulatory approval for any indication. Jupiter Neurosciences (JUNS) conducted a Phase I study demonstrating that JOTROL achieves over nine times higher bioavailability compared to resveratrol used in earlier clinical trials (e.g., Turner et al., MCI/Early Alzheimer's Disease trial, and Yui et al., Friedreich's Ataxia trial). The results of this Phase I study, which will be cross-referenced in all upcoming JOTROL trials, were published in the Journal of Alzheimer's Disease and AAPS Open in February 2022. JUNS is now advancing JOTROL toward a Phase IIa trial in Parkinson's Disease. FORWARD-LOOKING STATEMENTS Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations, including the Company's ability to generate revenues from the sale of JOTROL products to consumers through the DTC model. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company's final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company's securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Contact: Dave GentryRedChip Companies, Inc.1-407-644-42561-800-RED-CHIP (733-2447)JUNS@
Yahoo
30 minutes ago
- Yahoo
HONEYWELL COMPLETES ACQUISITION OF SUNDYNE TO EXPAND PROCESS INDUSTRY CAPABILITIES
$2.16 billion acquisition of Sundyne expands Honeywell's ESS product portfolio and aftermarket services, integrating critical equipment with automation and control systems powered by Honeywell Forge Sundyne brings approximately 1,000 skilled employees and significant aftermarket revenue generated from a large installed base Honeywell's global reach and strong customer relationships help accelerate market access and adoption of Sundyne's specialized products and services CHARLOTTE, N.C., June 9, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) today announced the completion of its acquisition of Sundyne from private equity firm Warburg Pincus for $2.16 billion in an all-cash transaction. The acquisition of Sundyne—a leader in the design, manufacturing, and aftermarket support of highly-engineered pumps and gas compressors for process industries—is expected to be immediately accretive to Honeywell's sales growth and segment margins as well as to adjusted EPS in the first full year of ownership. Sundyne's deep customer relationships, best-in-class products and technology will unlock strategic growth potential for Honeywell UOP's value chains in refining and petrochemicals, liquefied natural gas (LNG) and clean and renewable fuels. Unified under the Honeywell Forge platform, the combined solution provides a scalable, full-spectrum approach that positions Honeywell as a leader in the energy transition. "Merging Sundyne's differentiated products with Honeywell's leading technology and R&D capabilities positions our business for significant growth," said Ken West, President and CEO of Honeywell's Energy and Sustainability Solutions (ESS) segment. "By enhancing our end-to-end process technology and critical equipment offerings, this acquisition allows us to provide improved solutions for our customers." The completion of this acquisition follows Honeywell's announcement of the planned spin-offs of its Aerospace Technologies and Solstice Advanced Materials businesses, which will result in three publicly listed industry leaders with distinct strategies and growth drivers. Since December 2023, Honeywell has announced a number of strategic actions to drive organic growth and simplify its portfolio, including $13.5 billion of accretive acquisitions. In addition to Sundyne, these acquisitions include: the Access Solutions business from Carrier Global, Civitanavi Systems, CAES Systems, the LNG business from Air Products and Johnson Matthey's Catalyst Technologies Business. Honeywell also completed the sale of its Personal Protective Equipment business to Protective Industrial Products last month. About HoneywellHoneywell is an integrated operating company serving a broad range of industries and geographies around the world. Our business is aligned with three powerful megatrends – automation, the future of aviation and energy transition – underpinned by our Honeywell Accelerator operating system and Honeywell Forge IoT platform. As a trusted partner, we help organizations solve the world's toughest, most complex challenges, providing actionable solutions and innovations through our Aerospace Technologies, Industrial Automation, Building Automation and Energy and Sustainability Solutions business segments that help make the world smarter and safer as well as more secure and sustainable. For more news and information on Honeywell, please visit We describe many of the trends and other factors that drive our business and future results in this release. Such discussions contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). Forward-looking statements are those that address activities, events, or developments that management intends, expects, projects, believes, or anticipates will or may occur in the future and include statements related to the proposed spin-off of the Company's Advanced Materials business into a stand-alone, publicly traded company and the proposed separation of Automation and Aerospace. They are based on management's assumptions and assessments in light of past experience and trends, current economic and industry conditions, expected future developments, and other relevant factors, many of which are difficult to predict and outside of our control. They are not guarantees of future performance, and actual results, developments and business decisions may differ significantly from those envisaged by our forward-looking statements. We do not undertake to update or revise any of our forward-looking statements, except as required by applicable securities law. Our forward-looking statements are also subject to material risks and uncertainties, including ongoing macroeconomic and geopolitical risks, such as lower GDP growth or recession, supply chain disruptions, capital markets volatility, inflation, and certain regional conflicts, that can affect our performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this release can or will be achieved. These forward-looking statements should be considered in light of the information included in this release, our Form 10-K and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. Contacts:Media Investor Relations Stacey Jones Sean Meakim (980) 378-6258 (704) 627-6200 View original content to download multimedia: SOURCE Honeywell Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
